Liquidia Technologies Inc (LQDA) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Liquidia Corporation, a Delaware-based company, announced an update on the New Drug Application for their product YUTREPIA (treprostinil) inhalation powder on January 25, 2024, through a press release.
For further insights into LQDA stock, check out TipRanks’ Stock Analysis page.
